date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.441853836035252.
The log-likelihood improved by 2.13.
Iteration 2 of at most 500:
Optimizing with step length 0.777789295830524.
The log-likelihood improved by 2.693.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.562.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5869.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       3       12     1229     1016      795      385      384      347 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     305      210      132       92       53       24        6        6 
degree16 
       1 
1 
disease_progression 
H-positive risk:  870 852 131 887 443 145 869 462 92 58 129 62 
H-negative risk:  852 870 869 887 462 443 145 131 129 92 62 58 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
2 
disease_progression 
H-positive risk:  869 859 132 888 438 147 870 453 97 58 131 58 
H-negative risk:  859 869 870 888 453 438 147 132 131 97 58 58 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
64 new agents 
3 
disease_progression 
H-positive risk:  884 862 132 884 436 149 861 447 99 59 132 55 
H-negative risk:  862 884 861 884 447 436 149 132 132 99 55 59 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
4 
disease_progression 
H-positive risk:  889 866 131 891 430 151 858 437 98 61 132 56 
H-negative risk:  866 889 858 891 437 430 151 131 132 98 56 61 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
48 new agents 
5 
disease_progression 
H-positive risk:  894 868 131 894 426 154 852 434 97 60 133 57 
H-negative risk:  868 894 852 894 434 426 154 131 133 97 57 60 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 10 1 

clinical_engagement 
diagnosis 
demography 
66 new agents 
6 
disease_progression 
H-positive risk:  890 873 130 898 418 156 848 438 98 58 136 57 
H-negative risk:  873 890 848 898 438 418 156 130 136 98 57 58 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 15 1 

clinical_engagement 
diagnosis 
demography 
69 new agents 
7 
disease_progression 
H-positive risk:  898 881 131 905 408 152 850 428 97 60 135 55 
H-negative risk:  881 898 850 905 428 408 152 131 135 97 55 60 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 20 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
8 
disease_progression 
H-positive risk:  905 883 132 895 407 153 851 429 96 59 136 54 
H-negative risk:  883 905 851 895 429 407 153 132 136 96 54 59 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 24 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
9 
disease_progression 
H-positive risk:  911 883 131 888 407 155 853 424 97 59 138 54 
H-negative risk:  883 911 853 888 424 407 155 131 138 97 54 59 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 27 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
10 
disease_progression 
H-positive risk:  926 885 130 876 401 155 856 424 97 58 138 54 
H-negative risk:  885 926 856 876 424 401 155 130 138 97 54 58 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 28 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
11 
disease_progression 
H-positive risk:  922 884 133 875 398 158 858 423 98 57 140 54 
H-negative risk:  884 922 858 875 423 398 158 133 140 98 54 57 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 27 8 

clinical_engagement 
diagnosis 
demography 
57 new agents 
12 
disease_progression 
H-positive risk:  927 890 131 875 396 159 853 421 98 56 140 54 
H-negative risk:  890 927 853 875 421 396 159 131 140 98 54 56 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 31 9 

clinical_engagement 
diagnosis 
demography 
67 new agents 
13 
disease_progression 
H-positive risk:  843 831 115 941 392 141 945 411 117 55 156 53 
H-negative risk:  831 843 945 941 411 392 141 115 156 117 53 55 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 32 9 

clinical_engagement 
diagnosis 
demography 
204 new agents 
14 
disease_progression 
H-positive risk:  872 859 126 887 413 142 914 402 112 57 160 56 
H-negative risk:  859 872 914 887 402 413 142 126 160 112 56 57 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
15 
disease_progression 
H-positive risk:  867 863 125 880 418 143 917 399 112 58 162 56 
H-negative risk:  863 867 917 880 399 418 143 125 162 112 56 58 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
16 
disease_progression 
H-positive risk:  873 865 125 880 425 142 915 388 111 56 162 58 
H-negative risk:  865 873 915 880 388 425 142 125 162 111 58 56 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 34 11 

clinical_engagement 
diagnosis 
demography 
46 new agents 
17 
disease_progression 
H-positive risk:  876 875 125 877 418 144 914 386 110 56 162 57 
H-negative risk:  875 876 914 877 386 418 144 125 162 110 57 56 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 32 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
18 
disease_progression 
H-positive risk:  883 884 124 870 414 145 912 384 112 57 159 56 
H-negative risk:  884 883 912 870 384 414 145 124 159 112 56 57 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
66 new agents 
19 
disease_progression 
H-positive risk:  885 897 125 872 410 146 910 374 111 57 159 54 
H-negative risk:  897 885 910 872 374 410 146 125 159 111 54 57 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
57 new agents 
20 
disease_progression 
H-positive risk:  888 906 123 875 408 147 900 372 112 56 161 52 
H-negative risk:  906 888 900 875 372 408 147 123 161 112 52 56 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 37 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
21 
disease_progression 
H-positive risk:  885 905 124 883 401 148 903 369 113 55 160 54 
H-negative risk:  905 885 903 883 369 401 148 124 160 113 54 55 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
22 
disease_progression 
H-positive risk:  888 907 124 888 399 148 903 363 113 55 157 55 
H-negative risk:  907 888 903 888 363 399 148 124 157 113 55 55 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 43 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
23 
disease_progression 
H-positive risk:  890 916 120 893 398 149 901 359 110 53 157 54 
H-negative risk:  916 890 901 893 359 398 149 120 157 110 54 53 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 46 14 

clinical_engagement 
diagnosis 
demography 
58 new agents 
24 
disease_progression 
H-positive risk:  895 917 122 894 399 148 896 351 112 54 158 54 
H-negative risk:  917 895 896 894 351 399 148 122 158 112 54 54 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 46 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
25 
disease_progression 
H-positive risk:  830 833 109 976 396 134 968 351 124 54 169 56 
H-negative risk:  833 830 968 976 351 396 134 109 169 124 56 54 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 47 14 

clinical_engagement 
diagnosis 
demography 
203 new agents 
26 
disease_progression 
H-positive risk:  850 857 115 942 414 137 931 362 128 48 158 58 
H-negative risk:  857 850 931 942 362 414 137 115 158 128 58 48 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 49 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
27 
disease_progression 
H-positive risk:  858 858 116 943 404 136 929 365 127 49 156 59 
H-negative risk:  858 858 929 943 365 404 136 116 156 127 59 49 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 50 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
28 
disease_progression 
H-positive risk:  863 869 117 940 399 137 927 362 128 47 151 60 
H-negative risk:  869 863 927 940 362 399 137 117 151 128 60 47 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 54 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
29 
disease_progression 
H-positive risk:  868 872 121 941 396 138 926 359 125 45 150 59 
H-negative risk:  872 868 926 941 359 396 138 121 150 125 59 45 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 57 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
30 
disease_progression 
H-positive risk:  859 877 122 944 398 139 918 362 127 44 151 59 
H-negative risk:  877 859 918 944 362 398 139 122 151 127 59 44 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 57 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
31 
disease_progression 
H-positive risk:  854 882 120 943 397 139 923 366 127 42 149 58 
H-negative risk:  882 854 923 943 366 397 139 120 149 127 58 42 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
32 
disease_progression 
H-positive risk:  865 889 121 936 393 139 921 364 125 42 147 58 
H-negative risk:  889 865 921 936 364 393 139 121 147 125 58 42 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
33 
disease_progression 
H-positive risk:  874 893 123 930 391 139 923 360 125 42 145 55 
H-negative risk:  893 874 923 930 360 391 139 123 145 125 55 42 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
43 new agents 
34 
disease_progression 
H-positive risk:  879 898 125 924 390 138 919 363 127 41 142 54 
H-negative risk:  898 879 919 924 363 390 138 125 142 127 54 41 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 59 18 

clinical_engagement 
diagnosis 
demography 
53 new agents 
35 
disease_progression 
H-positive risk:  884 892 126 922 391 138 925 358 125 41 144 54 
H-negative risk:  892 884 925 922 358 391 138 126 144 125 54 41 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 59 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
36 
disease_progression 
H-positive risk:  885 900 126 923 394 135 922 356 126 38 141 54 
H-negative risk:  900 885 922 923 356 394 135 126 141 126 54 38 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 58 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
37 
disease_progression 
H-positive risk:  805 851 121 976 393 129 1007 348 128 40 147 55 
H-negative risk:  851 805 1007 976 348 393 129 121 147 128 55 40 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 58 19 

clinical_engagement 
diagnosis 
demography 
160 new agents 
38 
disease_progression 
H-positive risk:  821 866 123 943 404 130 974 373 127 43 135 61 
H-negative risk:  866 821 974 943 373 404 130 123 135 127 61 43 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
39 
disease_progression 
H-positive risk:  824 875 126 930 402 133 978 371 126 43 134 58 
H-negative risk:  875 824 978 930 371 402 133 126 134 126 58 43 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 61 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
40 
disease_progression 
H-positive risk:  823 872 124 937 401 135 980 369 128 42 131 58 
H-negative risk:  872 823 980 937 369 401 135 124 131 128 58 42 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
41 
disease_progression 
H-positive risk:  823 874 126 941 393 136 982 367 127 42 131 58 
H-negative risk:  874 823 982 941 367 393 136 126 131 127 58 42 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 62 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
42 
disease_progression 
H-positive risk:  837 864 125 935 393 138 986 368 128 41 128 57 
H-negative risk:  864 837 986 935 368 393 138 125 128 128 57 41 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
43 
disease_progression 
H-positive risk:  842 874 126 930 385 138 987 367 126 43 127 55 
H-negative risk:  874 842 987 930 367 385 138 126 127 126 55 43 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
44 
disease_progression 
H-positive risk:  842 874 128 930 390 138 985 366 125 44 124 54 
H-negative risk:  874 842 985 930 366 390 138 128 124 125 54 44 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 64 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
45 
disease_progression 
H-positive risk:  848 879 127 927 389 138 986 363 125 39 124 55 
H-negative risk:  879 848 986 927 363 389 138 127 124 125 55 39 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
46 
disease_progression 
H-positive risk:  854 885 126 923 384 140 980 365 124 40 126 53 
H-negative risk:  885 854 980 923 365 384 140 126 126 124 53 40 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 67 14 

clinical_engagement 
diagnosis 
demography 
54 new agents 
47 
disease_progression 
H-positive risk:  859 881 125 925 388 139 982 363 123 39 127 49 
H-negative risk:  881 859 982 925 363 388 139 125 127 123 49 39 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 67 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
48 
disease_progression 
H-positive risk:  855 894 128 918 394 137 979 360 120 41 124 50 
H-negative risk:  894 855 979 918 360 394 137 128 124 120 50 41 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
53 new agents 
49 
disease_progression 
H-positive risk:  800 836 119 980 391 131 1028 360 131 40 132 52 
H-negative risk:  836 800 1028 980 360 391 131 119 132 131 52 40 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 64 15 

clinical_engagement 
diagnosis 
demography 
132 new agents 
50 
disease_progression 
H-positive risk:  811 847 115 948 417 135 996 378 125 42 134 52 
H-negative risk:  847 811 996 948 378 417 135 115 134 125 52 42 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 63 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
51 
disease_progression 
H-positive risk:  815 843 115 954 413 137 991 383 124 43 129 53 
H-negative risk:  843 815 991 954 383 413 137 115 129 124 53 43 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 63 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
52 
disease_progression 
H-positive risk:  823 847 117 946 410 138 984 388 123 46 128 50 
H-negative risk:  847 823 984 946 388 410 138 117 128 123 50 46 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 64 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
53 
disease_progression 
H-positive risk:  822 847 117 945 408 142 991 384 124 45 127 48 
H-negative risk:  847 822 991 945 384 408 142 117 127 124 48 45 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
54 
disease_progression 
H-positive risk:  819 847 118 947 406 141 991 385 130 44 123 49 
H-negative risk:  847 819 991 947 385 406 141 118 123 130 49 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 67 13 

clinical_engagement 
diagnosis 
demography 
60 new agents 
55 
disease_progression 
H-positive risk:  824 845 118 947 408 140 993 380 130 44 122 49 
H-negative risk:  845 824 993 947 380 408 140 118 122 130 49 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 67 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
56 
disease_progression 
H-positive risk:  824 842 119 946 407 140 992 390 128 44 117 51 
H-negative risk:  842 824 992 946 390 407 140 119 117 128 51 44 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 68 13 

clinical_engagement 
diagnosis 
demography 
62 new agents 
57 
disease_progression 
H-positive risk:  821 839 119 957 400 140 992 393 126 43 119 51 
H-negative risk:  839 821 992 957 393 400 140 119 119 126 51 43 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 69 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
58 
disease_progression 
H-positive risk:  822 850 120 944 401 140 994 387 126 44 123 49 
H-negative risk:  850 822 994 944 387 401 140 120 123 126 49 44 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
84 new agents 
59 
disease_progression 
H-positive risk:  824 852 121 948 399 138 989 386 127 45 122 49 
H-negative risk:  852 824 989 948 386 399 138 121 122 127 49 45 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 73 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
60 
disease_progression 
H-positive risk:  824 857 119 943 395 138 987 390 128 45 124 50 
H-negative risk:  857 824 987 943 390 395 138 119 124 128 50 45 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 72 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
61 
disease_progression 
H-positive risk:  779 804 107 997 396 127 1031 389 141 47 134 48 
H-negative risk:  804 779 1031 997 389 396 127 107 134 141 48 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 78 13 

clinical_engagement 
diagnosis 
demography 
117 new agents 
62 
disease_progression 
H-positive risk:  792 807 102 976 405 128 1011 408 142 48 129 52 
H-negative risk:  807 792 1011 976 408 405 128 102 129 142 52 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 80 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
63 
disease_progression 
H-positive risk:  796 804 103 974 407 129 1002 410 143 49 131 52 
H-negative risk:  804 796 1002 974 410 407 129 103 131 143 52 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
64 
disease_progression 
H-positive risk:  804 805 100 973 412 132 998 405 143 46 131 51 
H-negative risk:  805 804 998 973 405 412 132 100 131 143 51 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 79 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
65 
disease_progression 
H-positive risk:  807 801 99 979 410 130 995 405 142 47 133 52 
H-negative risk:  801 807 995 979 405 410 130 99 133 142 52 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 80 12 

clinical_engagement 
diagnosis 
demography 
64 new agents 
66 
disease_progression 
H-positive risk:  817 794 99 981 410 132 992 403 145 45 131 51 
H-negative risk:  794 817 992 981 403 410 132 99 131 145 51 45 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 78 12 

clinical_engagement 
diagnosis 
demography 
66 new agents 
67 
disease_progression 
H-positive risk:  817 794 99 985 408 130 987 397 150 46 133 54 
H-negative risk:  794 817 987 985 397 408 130 99 133 150 54 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
54 new agents 
68 
disease_progression 
H-positive risk:  812 794 101 993 406 125 987 395 150 47 136 54 
H-negative risk:  794 812 987 993 395 406 125 101 136 150 54 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
69 
disease_progression 
H-positive risk:  804 795 101 996 407 125 988 395 152 46 137 54 
H-negative risk:  795 804 988 996 395 407 125 101 137 152 54 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
70 
disease_progression 
H-positive risk:  811 796 101 987 399 125 996 394 154 46 139 52 
H-negative risk:  796 811 996 987 394 399 125 101 139 154 52 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
71 
disease_progression 
H-positive risk:  813 807 101 977 403 126 996 394 151 44 138 50 
H-negative risk:  807 813 996 977 394 403 126 101 138 151 50 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
72 
disease_progression 
H-positive risk:  821 803 101 982 397 125 997 394 152 44 137 47 
H-negative risk:  803 821 997 982 394 397 125 101 137 152 47 44 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
73 
disease_progression 
H-positive risk:  760 760 95 1029 396 115 1059 390 163 43 145 45 
H-negative risk:  760 760 1059 1029 390 396 115 95 145 163 45 43 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
109 new agents 
74 
disease_progression 
H-positive risk:  757 763 94 1024 404 116 1044 404 163 42 145 44 
H-negative risk:  763 757 1044 1024 404 404 116 94 145 163 44 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
75 
disease_progression 
H-positive risk:  757 772 93 1020 404 117 1037 408 162 42 143 45 
H-negative risk:  772 757 1037 1020 408 404 117 93 143 162 45 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
76 
disease_progression 
H-positive risk:  754 778 92 1008 410 118 1044 405 160 41 146 44 
H-negative risk:  778 754 1044 1008 405 410 118 92 146 160 44 41 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
77 
disease_progression 
H-positive risk:  752 783 90 1011 406 112 1053 405 159 40 145 44 
H-negative risk:  783 752 1053 1011 405 406 112 90 145 159 44 40 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
78 
disease_progression 
H-positive risk:  751 782 90 1014 406 114 1048 402 164 38 146 45 
H-negative risk:  782 751 1048 1014 402 406 114 90 146 164 45 38 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
79 
disease_progression 
H-positive risk:  749 783 90 1019 406 116 1042 400 165 39 145 46 
H-negative risk:  783 749 1042 1019 400 406 116 90 145 165 46 39 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
55 new agents 
80 
disease_progression 
H-positive risk:  747 781 90 1019 401 114 1045 404 168 39 144 48 
H-negative risk:  781 747 1045 1019 404 401 114 90 144 168 48 39 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
81 
disease_progression 
H-positive risk:  752 783 90 1016 397 113 1045 404 171 39 144 46 
H-negative risk:  783 752 1045 1016 404 397 113 90 144 171 46 39 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
82 
disease_progression 
H-positive risk:  750 782 91 1020 390 113 1051 402 169 40 145 47 
H-negative risk:  782 750 1051 1020 402 390 113 91 145 169 47 40 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
83 
disease_progression 
H-positive risk:  752 785 91 1015 385 113 1055 403 170 42 142 47 
H-negative risk:  785 752 1055 1015 403 385 113 91 142 170 47 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
84 
disease_progression 
H-positive risk:  757 785 92 1013 378 114 1053 407 171 43 139 48 
H-negative risk:  785 757 1053 1013 407 378 114 92 139 171 48 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
54 new agents 
85 
disease_progression 
H-positive risk:  719 732 89 1058 377 111 1104 403 177 39 143 48 
H-negative risk:  732 719 1104 1058 403 377 111 89 143 177 48 39 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
126 new agents 
86 
disease_progression 
H-positive risk:  716 740 90 1052 378 114 1088 412 174 42 141 53 
H-negative risk:  740 716 1088 1052 412 378 114 90 141 174 53 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
87 
disease_progression 
H-positive risk:  718 737 91 1050 382 116 1085 420 168 43 137 53 
H-negative risk:  737 718 1085 1050 420 382 116 91 137 168 53 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
88 
disease_progression 
H-positive risk:  722 738 90 1049 381 114 1083 426 167 41 135 54 
H-negative risk:  738 722 1083 1049 426 381 114 90 135 167 54 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
89 
disease_progression 
H-positive risk:  718 742 91 1051 387 114 1087 415 163 41 136 55 
H-negative risk:  742 718 1087 1051 415 387 114 91 136 163 55 41 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
90 
disease_progression 
H-positive risk:  720 749 93 1050 395 112 1086 409 159 38 133 56 
H-negative risk:  749 720 1086 1050 409 395 112 93 133 159 56 38 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
91 
disease_progression 
H-positive risk:  722 749 91 1060 390 115 1086 400 152 40 136 59 
H-negative risk:  749 722 1086 1060 400 390 115 91 136 152 59 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
92 
disease_progression 
H-positive risk:  734 750 90 1062 384 116 1090 394 150 38 137 55 
H-negative risk:  750 734 1090 1062 394 384 116 90 137 150 55 38 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
93 
disease_progression 
H-positive risk:  733 758 91 1060 373 115 1094 395 149 38 137 57 
H-negative risk:  758 733 1094 1060 395 373 115 91 137 149 57 38 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
94 
disease_progression 
H-positive risk:  726 756 87 1061 369 116 1109 394 148 38 137 59 
H-negative risk:  756 726 1109 1061 394 369 116 87 137 148 59 38 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
46 new agents 
95 
disease_progression 
H-positive risk:  715 754 88 1058 371 117 1116 400 146 36 137 62 
H-negative risk:  754 715 1116 1058 400 371 117 88 137 146 62 36 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
96 
disease_progression 
H-positive risk:  718 753 90 1066 376 116 1104 399 146 36 136 60 
H-negative risk:  753 718 1104 1066 399 376 116 90 136 146 60 36 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
97 
disease_progression 
H-positive risk:  691 710 84 1105 373 109 1132 403 154 36 146 57 
H-negative risk:  710 691 1132 1105 403 373 109 84 146 154 57 36 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
115 new agents 
98 
disease_progression 
H-positive risk:  699 706 86 1101 371 108 1121 417 152 39 147 53 
H-negative risk:  706 699 1121 1101 417 371 108 86 147 152 53 39 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
99 
disease_progression 
H-positive risk:  701 711 86 1097 372 108 1116 412 153 40 149 55 
H-negative risk:  711 701 1116 1097 412 372 108 86 149 153 55 40 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
100 
disease_progression 
H-positive risk:  711 708 89 1097 372 106 1113 413 154 38 148 51 
H-negative risk:  708 711 1113 1097 413 372 106 89 148 154 51 38 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
101 
disease_progression 
H-positive risk:  717 706 85 1083 371 110 1122 412 157 38 151 48 
H-negative risk:  706 717 1122 1083 412 371 110 85 151 157 48 38 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
102 
disease_progression 
H-positive risk:  711 708 85 1090 368 111 1126 409 160 35 153 44 
H-negative risk:  708 711 1126 1090 409 368 111 85 153 160 44 35 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
103 
disease_progression 
H-positive risk:  715 702 86 1098 364 109 1125 410 155 38 155 43 
H-negative risk:  702 715 1125 1098 410 364 109 86 155 155 43 38 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
104 
disease_progression 
H-positive risk:  715 710 86 1092 360 111 1128 414 151 37 152 44 
H-negative risk:  710 715 1128 1092 414 360 111 86 152 151 44 37 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
105 
disease_progression 
H-positive risk:  721 714 87 1084 361 112 1131 410 148 36 149 47 
H-negative risk:  714 721 1131 1084 410 361 112 87 149 148 47 36 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
106 
disease_progression 
H-positive risk:  720 722 90 1075 361 112 1137 406 145 36 146 50 
H-negative risk:  722 720 1137 1075 406 361 112 90 146 145 50 36 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
107 
disease_progression 
H-positive risk:  716 712 92 1071 366 113 1142 408 144 38 148 50 
H-negative risk:  712 716 1142 1071 408 366 113 92 148 144 50 38 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
108 
disease_progression 
H-positive risk:  717 714 91 1073 361 115 1137 410 143 39 148 52 
H-negative risk:  714 717 1137 1073 410 361 115 91 148 143 52 39 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
109 
disease_progression 
H-positive risk:  679 667 87 1122 356 110 1170 410 152 40 153 54 
H-negative risk:  667 679 1170 1122 410 356 110 87 153 152 54 40 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
100 new agents 
110 
disease_progression 
H-positive risk:  668 669 85 1111 377 110 1165 415 153 39 153 55 
H-negative risk:  669 668 1165 1111 415 377 110 85 153 153 55 39 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 66 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
111 
disease_progression 
H-positive risk:  664 675 85 1110 372 111 1172 412 154 40 152 53 
H-negative risk:  675 664 1172 1110 412 372 111 85 152 154 53 40 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
112 
disease_progression 
H-positive risk:  670 678 80 1111 375 110 1173 406 152 42 150 53 
H-negative risk:  678 670 1173 1111 406 375 110 80 150 152 53 42 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
113 
disease_progression 
H-positive risk:  675 676 81 1111 374 109 1167 409 151 44 150 53 
H-negative risk:  676 675 1167 1111 409 374 109 81 150 151 53 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
96 new agents 
114 
disease_progression 
H-positive risk:  676 677 81 1115 374 108 1161 405 153 45 147 58 
H-negative risk:  677 676 1161 1115 405 374 108 81 147 153 58 45 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
115 
disease_progression 
H-positive risk:  675 687 82 1108 370 108 1171 402 149 45 147 56 
H-negative risk:  687 675 1171 1108 402 370 108 82 147 149 56 45 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
116 
disease_progression 
H-positive risk:  681 690 81 1109 370 107 1170 399 146 45 147 55 
H-negative risk:  690 681 1170 1109 399 370 107 81 147 146 55 45 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
117 
disease_progression 
H-positive risk:  684 697 84 1102 369 105 1169 396 149 45 148 52 
H-negative risk:  697 684 1169 1102 396 369 105 84 148 149 52 45 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  674 693 84 1106 368 106 1181 392 149 44 151 52 
H-negative risk:  693 674 1181 1106 392 368 106 84 151 149 52 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 73 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
119 
disease_progression 
H-positive risk:  673 690 84 1101 375 107 1179 393 151 45 150 52 
H-negative risk:  690 673 1179 1101 393 375 107 84 150 151 52 45 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
80 new agents 
120 
disease_progression 
H-positive risk:  670 690 86 1094 371 105 1177 407 152 46 149 53 
H-negative risk:  690 670 1177 1094 407 371 105 86 149 152 53 46 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
80 new agents 
121 
disease_progression 
H-positive risk:  647 651 85 1122 374 100 1200 414 151 47 156 53 
H-negative risk:  651 647 1200 1122 414 374 100 85 156 151 53 47 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 76 14 

clinical_engagement 
diagnosis 
demography 
89 new agents 
122 
disease_progression 
H-positive risk:  645 647 86 1119 373 100 1192 431 150 46 160 51 
H-negative risk:  647 645 1192 1119 431 373 100 86 160 150 51 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
96 new agents 
123 
disease_progression 
H-positive risk:  648 653 86 1113 375 99 1186 434 146 48 160 52 
H-negative risk:  653 648 1186 1113 434 375 99 86 160 146 52 48 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
124 
disease_progression 
H-positive risk:  656 658 85 1112 369 98 1185 428 146 47 160 56 
H-negative risk:  658 656 1185 1112 428 369 98 85 160 146 56 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
125 
disease_progression 
H-positive risk:  662 655 85 1110 368 99 1181 430 149 46 159 56 
H-negative risk:  655 662 1181 1110 430 368 99 85 159 149 56 46 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
126 
disease_progression 
H-positive risk:  661 661 83 1102 370 102 1181 434 148 44 159 55 
H-negative risk:  661 661 1181 1102 434 370 102 83 159 148 55 44 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
127 
disease_progression 
H-positive risk:  663 660 82 1111 371 103 1178 427 149 45 160 51 
H-negative risk:  660 663 1178 1111 427 371 103 82 160 149 51 45 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
128 
disease_progression 
H-positive risk:  658 666 82 1107 374 102 1186 426 146 42 160 51 
H-negative risk:  666 658 1186 1107 426 374 102 82 160 146 51 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
129 
disease_progression 
H-positive risk:  656 659 83 1121 364 105 1188 430 145 42 157 50 
H-negative risk:  659 656 1188 1121 430 364 105 83 157 145 50 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
130 
disease_progression 
H-positive risk:  657 654 83 1127 371 104 1189 425 142 44 156 48 
H-negative risk:  654 657 1189 1127 425 371 104 83 156 142 48 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
131 
disease_progression 
H-positive risk:  649 663 83 1123 368 103 1196 423 146 43 156 47 
H-negative risk:  663 649 1196 1123 423 368 103 83 156 146 47 43 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
132 
disease_progression 
H-positive risk:  658 658 84 1132 374 105 1185 416 142 45 155 46 
H-negative risk:  658 658 1185 1132 416 374 105 84 155 142 46 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
133 
disease_progression 
H-positive risk:  666 664 86 1131 380 103 1177 409 139 47 154 44 
H-negative risk:  664 666 1177 1131 409 380 103 86 154 139 44 47 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
112 new agents 
134 
disease_progression 
H-positive risk:  667 665 86 1123 383 111 1165 411 136 49 158 46 
H-negative risk:  665 667 1165 1123 411 383 111 86 158 136 46 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
135 
disease_progression 
H-positive risk:  668 661 86 1125 387 108 1171 405 134 52 156 47 
H-negative risk:  661 668 1171 1125 405 387 108 86 156 134 47 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
136 
disease_progression 
H-positive risk:  676 661 87 1116 391 106 1170 407 131 50 159 46 
H-negative risk:  661 676 1170 1116 407 391 106 87 159 131 46 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
137 
disease_progression 
H-positive risk:  683 662 89 1118 385 106 1167 405 131 53 157 44 
H-negative risk:  662 683 1167 1118 405 385 106 89 157 131 44 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
138 
disease_progression 
H-positive risk:  681 659 87 1129 381 104 1168 404 134 54 157 42 
H-negative risk:  659 681 1168 1129 404 381 104 87 157 134 42 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
139 
disease_progression 
H-positive risk:  687 666 88 1124 387 103 1154 402 134 55 157 43 
H-negative risk:  666 687 1154 1124 402 387 103 88 157 134 43 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
140 
disease_progression 
H-positive risk:  686 660 89 1122 390 105 1152 409 134 56 156 41 
H-negative risk:  660 686 1152 1122 409 390 105 89 156 134 41 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
141 
disease_progression 
H-positive risk:  682 670 87 1123 392 104 1145 410 131 56 160 40 
H-negative risk:  670 682 1145 1123 410 392 104 87 160 131 40 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
142 
disease_progression 
H-positive risk:  683 670 85 1124 391 102 1151 408 131 56 160 39 
H-negative risk:  670 683 1151 1124 408 391 102 85 160 131 39 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
143 
disease_progression 
H-positive risk:  681 677 84 1128 387 101 1152 408 130 54 160 38 
H-negative risk:  677 681 1152 1128 408 387 101 84 160 130 38 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
144 
disease_progression 
H-positive risk:  670 685 82 1137 383 102 1146 404 133 57 162 39 
H-negative risk:  685 670 1146 1137 404 383 102 82 162 133 39 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
145 
disease_progression 
H-positive risk:  667 680 82 1129 390 103 1151 403 135 57 164 39 
H-negative risk:  680 667 1151 1129 403 390 103 82 164 135 39 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
98 new agents 
146 
disease_progression 
H-positive risk:  666 675 80 1128 400 102 1140 410 131 59 161 48 
H-negative risk:  675 666 1140 1128 410 400 102 80 161 131 48 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  659 672 81 1119 410 100 1140 417 133 61 160 48 
H-negative risk:  672 659 1140 1119 417 410 100 81 160 133 48 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
148 
disease_progression 
H-positive risk:  661 670 81 1119 406 101 1137 417 139 62 160 47 
H-negative risk:  670 661 1137 1119 417 406 101 81 160 139 47 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
149 
disease_progression 
H-positive risk:  658 673 81 1129 394 96 1144 414 141 63 161 46 
H-negative risk:  673 658 1144 1129 414 394 96 81 161 141 46 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
150 
disease_progression 
H-positive risk:  663 681 78 1127 390 95 1141 417 138 62 161 47 
H-negative risk:  681 663 1141 1127 417 390 95 78 161 138 47 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
151 
disease_progression 
H-positive risk:  664 682 78 1120 393 94 1141 418 140 63 160 47 
H-negative risk:  682 664 1141 1120 418 393 94 78 160 140 47 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
152 
disease_progression 
H-positive risk:  659 686 79 1115 391 94 1140 424 140 63 161 48 
H-negative risk:  686 659 1140 1115 424 391 94 79 161 140 48 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
153 
disease_progression 
H-positive risk:  659 691 81 1113 393 94 1140 418 143 61 162 45 
H-negative risk:  691 659 1140 1113 418 393 94 81 162 143 45 61 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
154 
disease_progression 
H-positive risk:  662 689 79 1110 397 96 1143 414 144 59 164 43 
H-negative risk:  689 662 1143 1110 414 397 96 79 164 144 43 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  658 696 79 1115 389 96 1151 415 140 54 162 45 
H-negative risk:  696 658 1151 1115 415 389 96 79 162 140 45 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
156 
disease_progression 
H-positive risk:  654 698 80 1114 392 96 1143 416 141 55 166 45 
H-negative risk:  698 654 1143 1114 416 392 96 80 166 141 45 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
157 
disease_progression 
H-positive risk:  651 698 79 1115 398 96 1145 408 141 57 167 45 
H-negative risk:  698 651 1145 1115 408 398 96 79 167 141 45 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
158 
disease_progression 
H-positive risk:  650 707 83 1101 409 94 1123 420 145 58 166 44 
H-negative risk:  707 650 1123 1101 420 409 94 83 166 145 44 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
159 
disease_progression 
H-positive risk:  650 709 81 1107 410 91 1122 416 147 60 163 44 
H-negative risk:  709 650 1122 1107 416 410 91 81 163 147 44 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
160 
disease_progression 
H-positive risk:  658 708 81 1110 408 92 1120 410 150 57 162 44 
H-negative risk:  708 658 1120 1110 410 408 92 81 162 150 44 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 65 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
161 
disease_progression 
H-positive risk:  651 704 81 1117 403 93 1126 407 153 57 163 45 
H-negative risk:  704 651 1126 1117 407 403 93 81 163 153 45 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
162 
disease_progression 
H-positive risk:  654 701 83 1117 406 92 1121 409 155 54 161 47 
H-negative risk:  701 654 1121 1117 409 406 92 83 161 155 47 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
58 new agents 
163 
disease_progression 
H-positive risk:  653 694 82 1127 406 91 1124 405 154 54 161 49 
H-negative risk:  694 653 1124 1127 405 406 91 82 161 154 49 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
164 
disease_progression 
H-positive risk:  667 697 84 1121 408 91 1119 398 152 53 160 50 
H-negative risk:  697 667 1119 1121 398 408 91 84 160 152 50 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
165 
disease_progression 
H-positive risk:  666 692 82 1132 408 86 1118 397 155 52 162 50 
H-negative risk:  692 666 1118 1132 397 408 86 82 162 155 50 52 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 64 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
166 
disease_progression 
H-positive risk:  668 680 82 1149 402 85 1120 397 153 54 161 49 
H-negative risk:  680 668 1120 1149 397 402 85 82 161 153 49 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  671 669 80 1167 395 83 1113 401 155 54 162 50 
H-negative risk:  669 671 1113 1167 401 395 83 80 162 155 50 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
168 
disease_progression 
H-positive risk:  676 668 81 1176 391 81 1103 399 157 55 159 54 
H-negative risk:  668 676 1103 1176 399 391 81 81 159 157 54 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
169 
disease_progression 
H-positive risk:  688 668 81 1175 399 79 1093 399 154 56 156 52 
H-negative risk:  668 688 1093 1175 399 399 79 81 156 154 52 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
98 new agents 
170 
disease_progression 
H-positive risk:  683 669 82 1162 410 79 1084 399 162 58 156 56 
H-negative risk:  669 683 1084 1162 399 410 79 82 156 162 56 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
171 
disease_progression 
H-positive risk:  696 665 83 1160 408 82 1074 400 160 57 156 59 
H-negative risk:  665 696 1074 1160 400 408 82 83 156 160 59 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  701 667 84 1157 404 82 1083 393 156 60 155 58 
H-negative risk:  667 701 1083 1157 393 404 82 84 155 156 58 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
173 
disease_progression 
H-positive risk:  698 664 84 1165 405 83 1085 388 150 64 154 60 
H-negative risk:  664 698 1085 1165 388 405 83 84 154 150 60 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
174 
disease_progression 
H-positive risk:  696 666 87 1149 401 83 1098 389 154 62 157 58 
H-negative risk:  666 696 1098 1149 389 401 83 87 157 154 58 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
175 
disease_progression 
H-positive risk:  704 661 89 1152 401 83 1086 395 157 61 154 57 
H-negative risk:  661 704 1086 1152 395 401 83 89 154 157 57 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
176 
disease_progression 
H-positive risk:  698 671 89 1148 402 84 1088 394 155 60 152 59 
H-negative risk:  671 698 1088 1148 394 402 84 89 152 155 59 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
177 
disease_progression 
H-positive risk:  694 677 87 1150 404 86 1083 392 154 59 154 60 
H-negative risk:  677 694 1083 1150 392 404 86 87 154 154 60 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
178 
disease_progression 
H-positive risk:  688 683 87 1151 407 87 1094 384 152 58 152 57 
H-negative risk:  683 688 1094 1151 384 407 87 87 152 152 57 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
179 
disease_progression 
H-positive risk:  685 685 87 1146 409 87 1092 389 157 55 149 59 
H-negative risk:  685 685 1092 1146 389 409 87 87 149 157 59 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
180 
disease_progression 
H-positive risk:  687 685 87 1149 415 87 1085 380 160 54 153 58 
H-negative risk:  685 687 1085 1149 380 415 87 87 153 160 58 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
181 
disease_progression 
H-positive risk:  695 687 87 1140 422 88 1077 381 158 51 155 59 
H-negative risk:  687 695 1077 1140 381 422 88 87 155 158 59 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
94 new agents 
182 
disease_progression 
H-positive risk:  692 689 82 1128 438 88 1073 388 156 53 155 58 
H-negative risk:  689 692 1073 1128 388 438 88 82 155 156 58 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
183 
disease_progression 
H-positive risk:  691 690 83 1130 445 89 1072 381 154 54 153 58 
H-negative risk:  690 691 1072 1130 381 445 89 83 153 154 58 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
184 
disease_progression 
H-positive risk:  699 692 82 1123 447 90 1078 378 151 54 153 53 
H-negative risk:  692 699 1078 1123 378 447 90 82 153 151 53 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
185 
disease_progression 
H-positive risk:  704 695 84 1116 447 88 1069 385 149 53 155 55 
H-negative risk:  695 704 1069 1116 385 447 88 84 155 149 55 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
186 
disease_progression 
H-positive risk:  708 695 82 1115 450 88 1054 393 146 56 156 57 
H-negative risk:  695 708 1054 1115 393 450 88 82 156 146 57 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
187 
disease_progression 
H-positive risk:  704 698 80 1132 436 87 1054 391 145 56 159 58 
H-negative risk:  698 704 1054 1132 391 436 87 80 159 145 58 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
188 
disease_progression 
H-positive risk:  697 693 81 1137 435 85 1062 395 145 55 159 56 
H-negative risk:  693 697 1062 1137 395 435 85 81 159 145 56 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
189 
disease_progression 
H-positive risk:  694 699 83 1129 435 86 1063 394 147 58 157 55 
H-negative risk:  699 694 1063 1129 394 435 86 83 157 147 55 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
190 
disease_progression 
H-positive risk:  694 696 83 1134 431 85 1067 394 146 59 157 54 
H-negative risk:  696 694 1067 1134 394 431 85 83 157 146 54 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
191 
disease_progression 
H-positive risk:  693 694 85 1135 427 83 1066 397 150 59 156 55 
H-negative risk:  694 693 1066 1135 397 427 83 85 156 150 55 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
192 
disease_progression 
H-positive risk:  693 693 85 1141 432 82 1059 396 149 58 158 54 
H-negative risk:  693 693 1059 1141 396 432 82 85 158 149 54 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
193 
disease_progression 
H-positive risk:  685 698 84 1137 436 82 1069 394 148 58 155 54 
H-negative risk:  698 685 1069 1137 394 436 82 84 155 148 54 58 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
194 
disease_progression 
H-positive risk:  685 699 85 1134 440 86 1064 399 145 54 152 57 
H-negative risk:  699 685 1064 1134 399 440 86 85 152 145 57 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
195 
disease_progression 
H-positive risk:  686 704 88 1134 437 86 1059 394 150 52 155 55 
H-negative risk:  704 686 1059 1134 394 437 86 88 155 150 55 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
196 
disease_progression 
H-positive risk:  679 696 90 1128 443 83 1068 402 150 52 151 58 
H-negative risk:  696 679 1068 1128 402 443 83 90 151 150 58 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
197 
disease_progression 
H-positive risk:  681 687 90 1138 446 81 1063 402 149 52 152 59 
H-negative risk:  687 681 1063 1138 402 446 81 90 152 149 59 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
198 
disease_progression 
H-positive risk:  681 682 92 1142 443 81 1056 409 153 52 151 58 
H-negative risk:  682 681 1056 1142 409 443 81 92 151 153 58 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
199 
disease_progression 
H-positive risk:  681 688 92 1142 440 83 1055 407 156 50 152 54 
H-negative risk:  688 681 1055 1142 407 440 83 92 152 156 54 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
200 
disease_progression 
H-positive risk:  686 696 92 1130 442 83 1062 400 156 51 147 55 
H-negative risk:  696 686 1062 1130 400 442 83 92 147 156 55 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  690 699 91 1124 445 82 1069 395 161 47 146 51 
H-negative risk:  699 690 1069 1124 395 445 82 91 146 161 51 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
202 
disease_progression 
H-positive risk:  694 697 90 1129 439 83 1070 392 162 47 145 52 
H-negative risk:  697 694 1070 1129 392 439 83 90 145 162 52 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
203 
disease_progression 
H-positive risk:  688 697 89 1127 442 84 1073 395 158 49 147 51 
H-negative risk:  697 688 1073 1127 395 442 84 89 147 158 51 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
204 
disease_progression 
H-positive risk:  693 693 87 1129 444 83 1073 395 159 44 148 52 
H-negative risk:  693 693 1073 1129 395 444 83 87 148 159 52 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
205 
disease_progression 
H-positive risk:  696 694 89 1123 442 83 1079 393 159 41 152 49 
H-negative risk:  694 696 1079 1123 393 442 83 89 152 159 49 41 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  692 690 87 1120 444 86 1086 397 158 41 150 49 
H-negative risk:  690 692 1086 1120 397 444 86 87 150 158 49 41 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
207 
disease_progression 
H-positive risk:  686 691 88 1119 448 89 1080 397 155 44 150 53 
H-negative risk:  691 686 1080 1119 397 448 89 88 150 155 53 44 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
208 
disease_progression 
H-positive risk:  691 694 83 1116 442 88 1085 400 157 42 149 53 
H-negative risk:  694 691 1085 1116 400 442 88 83 149 157 53 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
209 
disease_progression 
H-positive risk:  696 691 84 1106 437 88 1084 415 157 42 151 49 
H-negative risk:  691 696 1084 1106 415 437 88 84 151 157 49 42 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
210 
disease_progression 
H-positive risk:  692 695 87 1110 426 89 1085 413 158 45 149 51 
H-negative risk:  695 692 1085 1110 413 426 89 87 149 158 51 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
211 
disease_progression 
H-positive risk:  692 702 88 1109 418 90 1090 412 158 45 146 50 
H-negative risk:  702 692 1090 1109 412 418 90 88 146 158 50 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
212 
disease_progression 
H-positive risk:  693 700 86 1119 416 91 1091 409 155 46 144 50 
H-negative risk:  700 693 1091 1119 409 416 91 86 144 155 50 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
62 new agents 
213 
disease_progression 
H-positive risk:  698 695 86 1119 424 88 1088 407 154 46 145 50 
H-negative risk:  695 698 1088 1119 407 424 88 86 145 154 50 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  700 697 83 1117 426 90 1086 403 154 46 148 50 
H-negative risk:  697 700 1086 1117 403 426 90 83 148 154 50 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
215 
disease_progression 
H-positive risk:  708 703 81 1108 424 90 1076 410 152 45 151 52 
H-negative risk:  703 708 1076 1108 410 424 90 81 151 152 52 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
216 
disease_progression 
H-positive risk:  701 706 80 1113 429 90 1077 410 151 43 151 49 
H-negative risk:  706 701 1077 1113 410 429 90 80 151 151 49 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
217 
disease_progression 
H-positive risk:  698 709 80 1091 439 91 1081 416 148 48 152 47 
H-negative risk:  709 698 1081 1091 416 439 91 80 152 148 47 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
93 new agents 
218 
disease_progression 
H-positive risk:  697 710 79 1082 441 94 1092 405 149 48 154 49 
H-negative risk:  710 697 1092 1082 405 441 94 79 154 149 49 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
219 
disease_progression 
H-positive risk:  702 710 78 1082 444 95 1078 414 148 48 155 46 
H-negative risk:  710 702 1078 1082 414 444 95 78 155 148 46 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
220 
disease_progression 
H-positive risk:  703 708 80 1080 440 95 1081 417 147 48 157 44 
H-negative risk:  708 703 1081 1080 417 440 95 80 157 147 44 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
221 
disease_progression 
H-positive risk:  700 703 79 1084 438 92 1090 415 148 47 159 45 
H-negative risk:  703 700 1090 1084 415 438 92 79 159 148 45 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
222 
disease_progression 
H-positive risk:  711 703 80 1079 436 91 1092 410 147 50 152 49 
H-negative risk:  703 711 1092 1079 410 436 91 80 152 147 49 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
223 
disease_progression 
H-positive risk:  723 697 83 1078 438 94 1080 409 146 48 151 53 
H-negative risk:  697 723 1080 1078 409 438 94 83 151 146 53 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
224 
disease_progression 
H-positive risk:  721 695 85 1079 438 95 1082 409 145 46 150 55 
H-negative risk:  695 721 1082 1079 409 438 95 85 150 145 55 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
58 new agents 
225 
disease_progression 
H-positive risk:  727 691 83 1078 444 96 1070 410 142 50 154 55 
H-negative risk:  691 727 1070 1078 410 444 96 83 154 142 55 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
226 
disease_progression 
H-positive risk:  724 695 82 1076 441 96 1073 414 143 52 151 53 
H-negative risk:  695 724 1073 1076 414 441 96 82 151 143 53 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
227 
disease_progression 
H-positive risk:  727 692 83 1084 443 96 1063 412 142 53 153 52 
H-negative risk:  692 727 1063 1084 412 443 96 83 153 142 52 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
228 
disease_progression 
H-positive risk:  733 687 81 1082 440 98 1058 419 141 56 153 52 
H-negative risk:  687 733 1058 1082 419 440 98 81 153 141 52 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
229 
disease_progression 
H-positive risk:  727 680 80 1084 445 99 1057 426 140 57 151 54 
H-negative risk:  680 727 1057 1084 426 445 99 80 151 140 54 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
230 
disease_progression 
H-positive risk:  723 679 79 1081 442 99 1061 431 140 59 151 55 
H-negative risk:  679 723 1061 1081 431 442 99 79 151 140 55 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
231 
disease_progression 
H-positive risk:  727 680 80 1087 441 99 1055 422 142 60 154 53 
H-negative risk:  680 727 1055 1087 422 441 99 80 154 142 53 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
232 
disease_progression 
H-positive risk:  731 676 78 1091 443 97 1052 427 138 60 154 53 
H-negative risk:  676 731 1052 1091 427 443 97 78 154 138 53 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
233 
disease_progression 
H-positive risk:  728 682 79 1087 438 99 1061 419 138 61 154 54 
H-negative risk:  682 728 1061 1087 419 438 99 79 154 138 54 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
234 
disease_progression 
H-positive risk:  719 682 79 1089 436 99 1075 413 140 60 156 52 
H-negative risk:  682 719 1075 1089 413 436 99 79 156 140 52 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
85 new agents 
235 
disease_progression 
H-positive risk:  714 684 78 1087 435 99 1084 411 143 54 157 54 
H-negative risk:  684 714 1084 1087 411 435 99 78 157 143 54 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
75 new agents 
236 
disease_progression 
H-positive risk:  718 684 80 1086 429 99 1080 419 144 54 156 51 
H-negative risk:  684 718 1080 1086 419 429 99 80 156 144 51 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 73 36 

clinical_engagement 
diagnosis 
demography 
69 new agents 
237 
disease_progression 
H-positive risk:  712 686 78 1081 440 99 1086 414 143 54 155 52 
H-negative risk:  686 712 1086 1081 414 440 99 78 155 143 52 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 74 37 

clinical_engagement 
diagnosis 
demography 
76 new agents 
238 
disease_progression 
H-positive risk:  709 683 79 1082 441 97 1085 414 144 57 155 54 
H-negative risk:  683 709 1085 1082 414 441 97 79 155 144 54 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
79 new agents 
239 
disease_progression 
H-positive risk:  713 680 79 1086 437 99 1082 422 144 55 151 52 
H-negative risk:  680 713 1082 1086 422 437 99 79 151 144 52 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 72 37 

clinical_engagement 
diagnosis 
demography 
81 new agents 
240 
disease_progression 
H-positive risk:  712 680 82 1077 444 97 1075 426 147 56 151 53 
H-negative risk:  680 712 1075 1077 426 444 97 82 151 147 53 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
68 new agents 
241 
disease_progression 
H-positive risk:  712 674 82 1079 441 97 1068 439 144 57 151 56 
H-negative risk:  674 712 1068 1079 439 441 97 82 151 144 56 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
242 
disease_progression 
H-positive risk:  713 675 85 1074 445 101 1075 428 141 59 148 56 
H-negative risk:  675 713 1075 1074 428 445 101 85 148 141 56 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
243 
disease_progression 
H-positive risk:  706 670 85 1087 436 99 1077 431 143 61 148 57 
H-negative risk:  670 706 1077 1087 431 436 99 85 148 143 57 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
244 
disease_progression 
H-positive risk:  708 667 82 1083 441 97 1079 429 142 63 151 58 
H-negative risk:  667 708 1079 1083 429 441 97 82 151 142 58 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
245 
disease_progression 
H-positive risk:  704 664 82 1075 451 96 1084 434 143 60 150 57 
H-negative risk:  664 704 1084 1075 434 451 96 82 150 143 57 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
246 
disease_progression 
H-positive risk:  707 666 80 1092 438 98 1079 437 140 60 149 54 
H-negative risk:  666 707 1079 1092 437 438 98 80 149 140 54 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 75 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
247 
disease_progression 
H-positive risk:  698 670 82 1088 449 95 1073 440 142 62 148 53 
H-negative risk:  670 698 1073 1088 440 449 95 82 148 142 53 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 74 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
248 
disease_progression 
H-positive risk:  696 665 83 1085 449 94 1081 443 144 61 147 52 
H-negative risk:  665 696 1081 1085 443 449 94 83 147 144 52 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
249 
disease_progression 
H-positive risk:  699 675 82 1081 437 92 1088 444 140 63 147 52 
H-negative risk:  675 699 1088 1081 444 437 92 82 147 140 52 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
76 new agents 
250 
disease_progression 
H-positive risk:  696 685 81 1071 438 92 1086 446 143 63 147 52 
H-negative risk:  685 696 1086 1071 446 438 92 81 147 143 52 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
251 
disease_progression 
H-positive risk:  700 685 83 1080 425 93 1084 448 146 60 144 52 
H-negative risk:  685 700 1084 1080 448 425 93 83 144 146 52 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
64 new agents 
252 
disease_progression 
H-positive risk:  695 685 82 1076 436 92 1081 459 141 57 145 51 
H-negative risk:  685 695 1081 1076 459 436 92 82 145 141 51 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
253 
disease_progression 
H-positive risk:  700 681 84 1077 437 89 1084 454 141 55 144 54 
H-negative risk:  681 700 1084 1077 454 437 89 84 144 141 54 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 70 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
254 
disease_progression 
H-positive risk:  701 684 80 1081 435 90 1086 455 141 54 142 51 
H-negative risk:  684 701 1086 1081 455 435 90 80 142 141 51 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 68 37 

clinical_engagement 
diagnosis 
demography 
82 new agents 
255 
disease_progression 
H-positive risk:  708 677 78 1085 438 90 1081 451 140 54 146 52 
H-negative risk:  677 708 1081 1085 451 438 90 78 146 140 52 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 71 37 

clinical_engagement 
diagnosis 
demography 
82 new agents 
256 
disease_progression 
H-positive risk:  716 674 80 1081 433 92 1083 447 136 57 147 54 
H-negative risk:  674 716 1083 1081 447 433 92 80 147 136 54 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 75 37 

clinical_engagement 
diagnosis 
demography 
82 new agents 
257 
disease_progression 
H-positive risk:  716 679 79 1077 428 92 1088 443 135 60 148 55 
H-negative risk:  679 716 1088 1077 443 428 92 79 148 135 55 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
258 
disease_progression 
H-positive risk:  710 681 78 1068 433 94 1090 447 133 63 148 55 
H-negative risk:  681 710 1090 1068 447 433 94 78 148 133 55 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  710 685 76 1062 442 94 1091 437 133 65 149 56 
H-negative risk:  685 710 1091 1062 437 442 94 76 149 133 56 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 71 35 

clinical_engagement 
diagnosis 
demography 
89 new agents 
260 
disease_progression 
H-positive risk:  719 688 73 1057 427 96 1096 435 134 67 151 57 
H-negative risk:  688 719 1096 1057 435 427 96 73 151 134 57 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 71 36 

clinical_engagement 
diagnosis 
demography 
82 new agents 
261 
disease_progression 
H-positive risk:  731 687 74 1048 431 97 1086 436 134 66 154 56 
H-negative risk:  687 731 1086 1048 436 431 97 74 154 134 56 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
262 
disease_progression 
H-positive risk:  738 675 74 1062 431 96 1082 433 135 66 152 56 
H-negative risk:  675 738 1082 1062 433 431 96 74 152 135 56 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
263 
disease_progression 
H-positive risk:  734 668 76 1066 430 94 1084 440 133 65 153 57 
H-negative risk:  668 734 1084 1066 440 430 94 76 153 133 57 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
264 
disease_progression 
H-positive risk:  732 677 78 1067 437 94 1077 432 131 66 153 56 
H-negative risk:  677 732 1077 1067 432 437 94 78 153 131 56 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
93 new agents 
265 
disease_progression 
H-positive risk:  729 679 80 1071 424 99 1078 434 133 65 152 56 
H-negative risk:  679 729 1078 1071 434 424 99 80 152 133 56 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
266 
disease_progression 
H-positive risk:  724 685 79 1076 416 98 1074 442 133 66 151 56 
H-negative risk:  685 724 1074 1076 442 416 98 79 151 133 56 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
95 new agents 
267 
disease_progression 
H-positive risk:  713 691 82 1063 426 98 1085 438 134 68 149 53 
H-negative risk:  691 713 1085 1063 438 426 98 82 149 134 53 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
268 
disease_progression 
H-positive risk:  713 692 82 1067 422 99 1089 431 138 67 149 51 
H-negative risk:  692 713 1089 1067 431 422 99 82 149 138 51 67 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
269 
disease_progression 
H-positive risk:  715 694 84 1066 418 100 1091 421 138 68 152 53 
H-negative risk:  694 715 1091 1066 421 418 100 84 152 138 53 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
56 new agents 
270 
disease_progression 
H-positive risk:  716 687 86 1065 414 95 1094 424 140 70 153 56 
H-negative risk:  687 716 1094 1065 424 414 95 86 153 140 56 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
271 
disease_progression 
H-positive risk:  716 686 86 1067 418 93 1087 428 139 69 152 59 
H-negative risk:  686 716 1087 1067 428 418 93 86 152 139 59 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 74 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
272 
disease_progression 
H-positive risk:  712 693 87 1063 416 93 1091 430 140 65 153 57 
H-negative risk:  693 712 1091 1063 430 416 93 87 153 140 57 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
273 
disease_progression 
H-positive risk:  714 694 86 1065 415 94 1090 427 140 64 155 56 
H-negative risk:  694 714 1090 1065 427 415 94 86 155 140 56 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
274 
disease_progression 
H-positive risk:  714 688 87 1060 419 94 1097 418 147 62 155 59 
H-negative risk:  688 714 1097 1060 418 419 94 87 155 147 59 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
275 
disease_progression 
H-positive risk:  712 688 86 1061 414 96 1098 422 148 61 155 59 
H-negative risk:  688 712 1098 1061 422 414 96 86 155 148 59 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
52 new agents 
276 
disease_progression 
H-positive risk:  709 684 84 1068 412 94 1098 423 149 62 155 62 
H-negative risk:  684 709 1098 1068 423 412 94 84 155 149 62 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
277 
disease_progression 
H-positive risk:  711 689 84 1073 406 94 1094 426 150 62 150 61 
H-negative risk:  689 711 1094 1073 426 406 94 84 150 150 61 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
278 
disease_progression 
H-positive risk:  708 685 86 1077 396 95 1102 429 149 64 150 59 
H-negative risk:  685 708 1102 1077 429 396 95 86 150 149 59 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
279 
disease_progression 
H-positive risk:  705 689 83 1076 398 92 1091 440 150 65 154 57 
H-negative risk:  689 705 1091 1076 440 398 92 83 154 150 57 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
280 
disease_progression 
H-positive risk:  712 689 84 1075 392 94 1084 445 153 61 154 57 
H-negative risk:  689 712 1084 1075 445 392 94 84 154 153 57 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
281 
disease_progression 
H-positive risk:  706 691 85 1077 387 94 1078 454 153 61 158 56 
H-negative risk:  691 706 1078 1077 454 387 94 85 158 153 56 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
282 
disease_progression 
H-positive risk:  702 697 87 1081 379 93 1078 456 157 57 162 51 
H-negative risk:  697 702 1078 1081 456 379 93 87 162 157 51 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
283 
disease_progression 
H-positive risk:  702 698 89 1070 388 94 1074 462 154 56 159 54 
H-negative risk:  698 702 1074 1070 462 388 94 89 159 154 54 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
284 
disease_progression 
H-positive risk:  702 694 89 1072 387 96 1072 462 157 56 159 54 
H-negative risk:  694 702 1072 1072 462 387 96 89 159 157 54 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
285 
disease_progression 
H-positive risk:  702 696 90 1073 378 96 1068 466 159 54 160 58 
H-negative risk:  696 702 1068 1073 466 378 96 90 160 159 58 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
286 
disease_progression 
H-positive risk:  700 691 90 1078 382 94 1071 460 159 56 160 59 
H-negative risk:  691 700 1071 1078 460 382 94 90 160 159 59 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
287 
disease_progression 
H-positive risk:  702 693 92 1072 386 95 1068 465 158 53 160 56 
H-negative risk:  693 702 1068 1072 465 386 95 92 160 158 56 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
288 
disease_progression 
H-positive risk:  706 696 88 1073 385 99 1065 465 157 51 159 56 
H-negative risk:  696 706 1065 1073 465 385 99 88 159 157 56 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
289 
disease_progression 
H-positive risk:  702 703 89 1071 379 99 1076 453 160 50 159 59 
H-negative risk:  703 702 1076 1071 453 379 99 89 159 160 59 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
290 
disease_progression 
H-positive risk:  708 695 88 1081 375 97 1080 449 162 50 154 61 
H-negative risk:  695 708 1080 1081 449 375 97 88 154 162 61 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
291 
disease_progression 
H-positive risk:  702 694 89 1082 377 98 1083 448 164 49 152 62 
H-negative risk:  694 702 1083 1082 448 377 98 89 152 164 62 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
292 
disease_progression 
H-positive risk:  708 688 93 1078 381 100 1077 443 164 52 155 61 
H-negative risk:  688 708 1077 1078 443 381 100 93 155 164 61 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
293 
disease_progression 
H-positive risk:  710 690 95 1078 380 98 1075 444 161 53 156 60 
H-negative risk:  690 710 1075 1078 444 380 98 95 156 161 60 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
103 new agents 
294 
disease_progression 
H-positive risk:  707 688 97 1079 370 98 1074 449 162 54 161 61 
H-negative risk:  688 707 1074 1079 449 370 98 97 161 162 61 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
295 
disease_progression 
H-positive risk:  712 677 95 1092 369 98 1068 454 156 55 161 63 
H-negative risk:  677 712 1068 1092 454 369 98 95 161 156 63 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
296 
disease_progression 
H-positive risk:  717 673 92 1089 378 101 1064 453 155 57 160 61 
H-negative risk:  673 717 1064 1089 453 378 101 92 160 155 61 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
297 
disease_progression 
H-positive risk:  713 670 93 1084 386 100 1070 449 155 61 159 60 
H-negative risk:  670 713 1070 1084 449 386 100 93 159 155 60 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
298 
disease_progression 
H-positive risk:  711 669 92 1095 383 100 1073 445 153 62 160 57 
H-negative risk:  669 711 1073 1095 445 383 100 92 160 153 57 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
299 
disease_progression 
H-positive risk:  711 666 92 1093 385 102 1075 444 150 66 160 56 
H-negative risk:  666 711 1075 1093 444 385 102 92 160 150 56 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
300 
disease_progression 
H-positive risk:  697 676 91 1086 394 102 1076 444 152 67 158 57 
H-negative risk:  676 697 1076 1086 444 394 102 91 158 152 57 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
301 
disease_progression 
H-positive risk:  692 681 94 1081 409 100 1071 440 153 68 155 56 
H-negative risk:  681 692 1071 1081 440 409 100 94 155 153 56 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
302 
disease_progression 
H-positive risk:  701 679 94 1083 401 105 1062 440 154 69 156 56 
H-negative risk:  679 701 1062 1083 440 401 105 94 156 154 56 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
303 
disease_progression 
H-positive risk:  700 676 94 1083 400 106 1066 446 152 68 155 54 
H-negative risk:  676 700 1066 1083 446 400 106 94 155 152 54 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
304 
disease_progression 
H-positive risk:  690 676 96 1083 398 103 1075 447 150 70 156 56 
H-negative risk:  676 690 1075 1083 447 398 103 96 156 150 56 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
305 
disease_progression 
H-positive risk:  690 679 98 1077 400 102 1080 443 147 72 155 57 
H-negative risk:  679 690 1080 1077 443 400 102 98 155 147 57 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
306 
disease_progression 
H-positive risk:  696 676 98 1086 403 100 1073 442 142 70 157 57 
H-negative risk:  676 696 1073 1086 442 403 100 98 157 142 57 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
307 
disease_progression 
H-positive risk:  701 680 99 1083 408 97 1074 435 146 64 155 58 
H-negative risk:  680 701 1074 1083 435 408 97 99 155 146 58 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
308 
disease_progression 
H-positive risk:  701 679 98 1086 405 96 1076 435 149 62 158 55 
H-negative risk:  679 701 1076 1086 435 405 96 98 158 149 55 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
309 
disease_progression 
H-positive risk:  699 677 101 1083 407 96 1080 438 150 56 157 56 
H-negative risk:  677 699 1080 1083 438 407 96 101 157 150 56 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
310 
disease_progression 
H-positive risk:  700 672 104 1078 413 100 1078 435 150 58 155 57 
H-negative risk:  672 700 1078 1078 435 413 100 104 155 150 57 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
311 
disease_progression 
H-positive risk:  703 671 104 1082 411 97 1081 433 151 52 154 61 
H-negative risk:  671 703 1081 1082 433 411 97 104 154 151 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
312 
disease_progression 
H-positive risk:  703 674 104 1082 412 97 1082 430 146 53 155 62 
H-negative risk:  674 703 1082 1082 430 412 97 104 155 146 62 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
313 
disease_progression 
H-positive risk:  707 668 105 1084 407 98 1086 431 143 54 157 60 
H-negative risk:  668 707 1086 1084 431 407 98 105 157 143 60 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
314 
disease_progression 
H-positive risk:  695 660 108 1102 407 95 1080 434 144 55 159 61 
H-negative risk:  660 695 1080 1102 434 407 95 108 159 144 61 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
315 
disease_progression 
H-positive risk:  699 662 109 1110 405 96 1073 431 142 54 158 61 
H-negative risk:  662 699 1073 1110 431 405 96 109 158 142 61 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
316 
disease_progression 
H-positive risk:  709 660 109 1113 401 96 1075 428 140 53 156 60 
H-negative risk:  660 709 1075 1113 428 401 96 109 156 140 60 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
317 
disease_progression 
H-positive risk:  708 658 110 1114 397 97 1081 429 137 54 158 57 
H-negative risk:  658 708 1081 1114 429 397 97 110 158 137 57 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
318 
disease_progression 
H-positive risk:  699 659 110 1122 392 97 1085 429 138 55 153 61 
H-negative risk:  659 699 1085 1122 429 392 97 110 153 138 61 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
319 
disease_progression 
H-positive risk:  698 651 110 1128 394 102 1085 424 138 55 155 60 
H-negative risk:  651 698 1085 1128 424 394 102 110 155 138 60 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
320 
disease_progression 
H-positive risk:  699 655 110 1115 400 100 1088 418 140 56 158 61 
H-negative risk:  655 699 1088 1115 418 400 100 110 158 140 61 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
321 
disease_progression 
H-positive risk:  696 654 111 1121 402 103 1087 408 139 57 159 63 
H-negative risk:  654 696 1087 1121 408 402 103 111 159 139 63 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
322 
disease_progression 
H-positive risk:  693 652 111 1128 397 102 1097 404 141 55 158 62 
H-negative risk:  652 693 1097 1128 404 397 102 111 158 141 62 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
323 
disease_progression 
H-positive risk:  690 664 110 1123 393 101 1101 402 143 54 156 63 
H-negative risk:  664 690 1101 1123 402 393 101 110 156 143 63 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
324 
disease_progression 
H-positive risk:  688 658 110 1132 385 101 1090 418 144 58 155 61 
H-negative risk:  658 688 1090 1132 418 385 101 110 155 144 61 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
325 
disease_progression 
H-positive risk:  681 660 107 1142 386 99 1089 414 147 56 157 62 
H-negative risk:  660 681 1089 1142 414 386 99 107 157 147 62 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
326 
disease_progression 
H-positive risk:  676 660 105 1151 380 98 1088 419 146 58 157 62 
H-negative risk:  660 676 1088 1151 419 380 98 105 157 146 62 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
327 
disease_progression 
H-positive risk:  675 653 103 1145 385 102 1090 424 145 59 157 62 
H-negative risk:  653 675 1090 1145 424 385 102 103 157 145 62 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
95 new agents 
328 
disease_progression 
H-positive risk:  670 653 104 1145 386 104 1091 426 141 56 162 62 
H-negative risk:  653 670 1091 1145 426 386 104 104 162 141 62 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
329 
disease_progression 
H-positive risk:  667 654 102 1151 384 104 1094 427 139 54 160 64 
H-negative risk:  654 667 1094 1151 427 384 104 102 160 139 64 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
330 
disease_progression 
H-positive risk:  669 658 96 1153 386 103 1088 435 135 53 159 65 
H-negative risk:  658 669 1088 1153 435 386 103 96 159 135 65 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
331 
disease_progression 
H-positive risk:  661 645 96 1155 397 101 1093 442 136 53 159 62 
H-negative risk:  645 661 1093 1155 442 397 101 96 159 136 62 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
332 
disease_progression 
H-positive risk:  662 646 93 1154 398 99 1085 440 139 57 164 63 
H-negative risk:  646 662 1085 1154 440 398 99 93 164 139 63 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
333 
disease_progression 
H-positive risk:  665 645 91 1152 398 99 1093 429 137 59 167 65 
H-negative risk:  645 665 1093 1152 429 398 99 91 167 137 65 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
334 
disease_progression 
H-positive risk:  659 651 92 1153 399 100 1092 428 135 59 169 63 
H-negative risk:  651 659 1092 1153 428 399 100 92 169 135 63 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
335 
disease_progression 
H-positive risk:  663 657 93 1148 402 101 1089 426 133 58 166 64 
H-negative risk:  657 663 1089 1148 426 402 101 93 166 133 64 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
336 
disease_progression 
H-positive risk:  656 656 95 1145 401 101 1097 418 137 61 168 65 
H-negative risk:  656 656 1097 1145 418 401 101 95 168 137 65 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
337 
disease_progression 
H-positive risk:  652 654 93 1149 408 100 1096 416 137 60 170 65 
H-negative risk:  654 652 1096 1149 416 408 100 93 170 137 65 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
338 
disease_progression 
H-positive risk:  651 664 94 1120 422 99 1093 416 141 60 171 69 
H-negative risk:  664 651 1093 1120 416 422 99 94 171 141 69 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
339 
disease_progression 
H-positive risk:  653 667 93 1115 419 99 1100 416 142 58 170 68 
H-negative risk:  667 653 1100 1115 416 419 99 93 170 142 68 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
340 
disease_progression 
H-positive risk:  653 675 94 1104 420 98 1098 411 146 59 172 70 
H-negative risk:  675 653 1098 1104 411 420 98 94 172 146 70 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
341 
disease_progression 
H-positive risk:  655 670 96 1111 416 92 1095 415 150 61 172 67 
H-negative risk:  670 655 1095 1111 415 416 92 96 172 150 67 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
342 
disease_progression 
H-positive risk:  650 667 96 1123 417 94 1098 405 150 61 172 67 
H-negative risk:  667 650 1098 1123 405 417 94 96 172 150 67 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
343 
disease_progression 
H-positive risk:  652 660 97 1126 419 93 1091 411 152 58 176 65 
H-negative risk:  660 652 1091 1126 411 419 93 97 176 152 65 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
344 
disease_progression 
H-positive risk:  649 659 101 1131 417 89 1088 413 152 59 173 69 
H-negative risk:  659 649 1088 1131 413 417 89 101 173 152 69 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
345 
disease_progression 
H-positive risk:  652 654 102 1145 411 88 1094 402 152 58 175 67 
H-negative risk:  654 652 1094 1145 402 411 88 102 175 152 67 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
346 
disease_progression 
H-positive risk:  655 654 100 1141 419 89 1087 401 156 59 174 65 
H-negative risk:  654 655 1087 1141 401 419 89 100 174 156 65 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
347 
disease_progression 
H-positive risk:  652 652 101 1144 423 91 1092 396 156 58 169 66 
H-negative risk:  652 652 1092 1144 396 423 91 101 169 156 66 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
348 
disease_progression 
H-positive risk:  652 660 101 1134 421 94 1102 395 155 54 171 61 
H-negative risk:  660 652 1102 1134 395 421 94 101 171 155 61 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
349 
disease_progression 
H-positive risk:  651 658 100 1134 419 98 1105 396 155 51 174 59 
H-negative risk:  658 651 1105 1134 396 419 98 100 174 155 59 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
350 
disease_progression 
H-positive risk:  649 660 100 1130 422 97 1104 404 153 51 174 56 
H-negative risk:  660 649 1104 1130 404 422 97 100 174 153 56 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
351 
disease_progression 
H-positive risk:  641 668 105 1128 418 95 1107 400 153 52 174 59 
H-negative risk:  668 641 1107 1128 400 418 95 105 174 153 59 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
352 
disease_progression 
H-positive risk:  646 663 104 1129 423 95 1103 401 151 54 173 58 
H-negative risk:  663 646 1103 1129 401 423 95 104 173 151 58 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
353 
disease_progression 
H-positive risk:  646 663 104 1125 426 96 1098 408 150 55 172 57 
H-negative risk:  663 646 1098 1125 408 426 96 104 172 150 57 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
354 
disease_progression 
H-positive risk:  648 661 104 1131 425 97 1096 407 153 55 169 54 
H-negative risk:  661 648 1096 1131 407 425 97 104 169 153 54 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
355 
disease_progression 
H-positive risk:  657 669 103 1124 420 97 1085 412 157 53 169 54 
H-negative risk:  669 657 1085 1124 412 420 97 103 169 157 54 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
356 
disease_progression 
H-positive risk:  658 672 102 1115 426 99 1091 406 159 50 169 53 
H-negative risk:  672 658 1091 1115 406 426 99 102 169 159 53 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
357 
disease_progression 
H-positive risk:  650 666 101 1115 433 100 1099 407 160 48 168 53 
H-negative risk:  666 650 1099 1115 407 433 100 101 168 160 53 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
358 
disease_progression 
H-positive risk:  654 675 100 1110 433 102 1093 406 159 48 166 54 
H-negative risk:  675 654 1093 1110 406 433 102 100 166 159 54 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
359 
disease_progression 
H-positive risk:  657 675 99 1116 423 104 1087 412 158 50 163 56 
H-negative risk:  675 657 1087 1116 412 423 104 99 163 158 56 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
360 
disease_progression 
H-positive risk:  655 674 98 1110 427 106 1086 422 153 51 161 57 
H-negative risk:  674 655 1086 1110 422 427 106 98 161 153 57 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
Time difference of 17.90117 mins
This is task 6
date
